Baricade-DELAY Study

Are you in the early stages (Stage 1b or Stage 2) of Type 1 Diabetes?

This study is investigating whether baricitinib delays the onset of Stage 3 Type 1 diabetes in participants with Stage 1b or Stage 2 Type 1 diabetes.

Status: Open to recruitment.

To join this research study, you must:

• Be aged 1 year or over and under 36 years old
• Have stage 1b or stage 2 type 1 diabetes

Location: Cambridge Clinical Research Centre on Keith Day Road, next to the Addenbrooke’s Treatment Centre, and part of the Cambridge Biomedical Centre.

Find out more
Email: Jane Kennet